PeptideDB
de
EnglishEspañolDeutschPortuguês
PeptideKategorienVergleichLeitfädenGlossar

Vilon

Moderates Forschungsinteresse

KE Dipeptide | Thymus Immune Bioregulator

ImmunsystemLanglebigkeit

Vilon is a Khavinson bioregulator dipeptide (KE) consisting of lysine and glutamic acid, originally isolated from thymus gland extracts. Developed by Professor Vladimir Khavinson at the St.

Molekulare und Forschungsdaten

Sequenz
Lys-Glu
Molekulargewicht
275 Da
Halbwertszeit
Not established
Wege (Forschung)
oral, injectable
Lagerung
Oral capsules: room temperature; Lyophilized powder/reconstituted: 2-8°C refrigerated

Overview

Vilon is a Khavinson bioregulator dipeptide (KE) consisting of lysine and glutamic acid, originally isolated from thymus gland extracts. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it acts as a molecular signaling compound that restores normal gene expression and protein synthesis in immune and epithelial cells. Research shows Vilon increases mean lifespan by 20-40% in animal studies and suppresses tumor development.

Mechanism of action

Vilon works through epigenetic modulation, restoring chromatin structure and gene expression in immune cells. It stimulates thymocyte proliferation, activates T-helper cells, and increases the proliferative index in thymus tissue (from 26% to 37% in studies). The peptide modulates tyrosine phosphorylation of mitogen-activated cytoplasmic kinases and helps rejuvenate aged immune systems by restoring proper gene expression patterns.

Key research findings

  • Increases mean lifespan 20-40% in animal models
  • Suppresses tumor development
  • Stimulates thymocyte proliferation
  • Activates T-helper cells
  • Restores chromatin structure in aged lymphocytes
  • Enhances intestinal barrier function
  • Improves enzyme activity in aged tissue
  • Part of comprehensive longevity protocols

Research applications

Immune Support

  • Thymus Rejuvenation — Stimulates thymocyte proliferation and enlarges thymic lobules.
  • T-Cell Activation — Activates T-helper cells and improves immune response.
  • Age-Related Immune Decline — Restores chromatin structure and gene expression in aged lymphocytes.

Anti-Aging

  • Lifespan Extension — Long-term treatment increased mean lifespan 20-40% in rodent studies.
  • Tumor Suppression — Suppresses development of spontaneous and induced tumors.
  • Tissue Regeneration — Promotes recovery in tissues exposed to radiation damage.

GI Health

  • Intestinal Function — Restores brush border membrane enzyme levels in aged animals.
  • Barrier Function — Enhances intestinal barrier function in aged rats.

Vilon Häufig gestellte Fragen

How significant is the 20-40% lifespan extension from Vilon - is it proven in humans?+

Animal studies showed 20-40% mean lifespan increases with long-term Vilon treatment plus tumor suppression. These are compelling preclinical findings but haven't been replicated in human longevity trials - lifespan extension is theorized based on mechanisms and animal models rather than clinical proof. Effects in humans are likely more modest.

Can Vilon be used continuously or must it follow the 10-20 day cycling protocol?+

Vilon follows Khavinson bioregulator cycling: 10-20 days on, then off, repeated 2-3 times yearly. Cycling allows the body's natural feedback mechanisms to maintain homeostasis and prevents tolerance. Continuous use isn't recommended and may blunt epigenetic effects through feedback inhibition.

Does Vilon improve intestinal health and can it help with digestive issues?+

Yes, Vilon restores brush border membrane enzyme levels and enhances intestinal barrier function in aged animals. This suggests potential benefits for age-related digestive decline and GI barrier integrity. However, direct clinical data for specific digestive conditions is limited - benefits are inferred from mechanisms.

Is Vilon the shortest bioregulator peptide and does size matter for absorption?+

Yes, Vilon is the shortest Khavinson peptide at just 2 amino acids, giving it excellent oral absorption. The dipeptide size allows convenient capsule administration with good GI bioavailability - making it more practical than longer peptide bioregulators requiring injection.

References

  1. [1]Peptide Bioregulators Increase LifespanBiogerontology
  2. [2]Vilon Effects on Aged LymphocytesBulletin of Experimental Biology and Medicine
  3. [3]Peptides Regulating Proliferative Activity in THP-1 CellsPMC
  4. [4]Short Peptide Immunoprotecting PropertiesAdvances in Gerontology

Verwandte Peptide

Chonluten

Moderate research

EDG Tripeptide | Bronchial/Lung Bioregulator

Chonluten is a Khavinson bioregulator tripeptide (EDG) derived from respiratory lung tissue. Developed at Russia's St.

ImmunsystemLanglebigkeit

Crystagen

Moderate research

EDP Tripeptide | Thymus Immune Bioregulator

Crystagen is a Khavinson bioregulator tripeptide (EDP) identified in thymalin with selective action on thymus tissues. Developed at Russia's St.

ImmunsystemLanglebigkeit

Glutathione

Extensively studied

L-Glutathione | Master Antioxidant Tripeptide

Glutathione is the body's master antioxidant, a tripeptide produced naturally by the liver.

LanglebigkeitImmunsystem

Livagen

Moderate research

KEDA Tetrapeptide | Liver Bioregulator

Livagen is a Khavinson bioregulator tetrapeptide (KEDA) with significant hepatoprotective and immunomodulatory properties.

LanglebigkeitImmunsystem